United States Biotechnology & Medical Research

Travere Therapeutics Inc (TVTX)

Track

Travere Therapeutics experienced significant insider trading activity recently, with executives and directors executing planned sales totaling approximately 1.73 million dollars. These divestments occurred amid a 40.9 percent stock price increase over the last quarter. The company's latest results financiers showed an earnings miss, while shares currently trade near their fifty-two week peak.
Ticker: TVTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Travere Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 12 Jun 2026
Value US$2,651,857.88 | Price 371.30 | Shares 89,995 (-39.6%)
Proposed sale 12 Jun 2026
Value US$207,485.99 | Price 29.50 | Shares 18,777
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-12 PlS Planned sale
1.2
Coughlin Timothy
Non-Executive Director
89,995 -39.6%
371.30
US$2,651,858 		89,995 -39.6% 371.30 US$2,651,858
2026-06-16 2026-06-12 PlS Planned sale
0.5
Baynes Roy D.
Non-Executive Director
23,810 +24.7%
347.44
US$3,483,999 		23,810 +24.7% 347.44 US$3,483,999
2026-06-12 2026-06-12 PrS Proposed sale
0.5
ROY BAYNES

Director

Non-Executive Director
54,170
161.52
US$2,410,536 		54,170 161.52 US$2,410,536
2026-06-12 2026-06-12 PrS Proposed sale
1.2
Coughlin Timothy

Director

Non-Executive Director
10,000
50.04
US$500,430 		10,000 50.04 US$500,430
2026-05-19 2026-05-15 PlS Planned sale
1.2
Coughlin Timothy
Non-Executive Director
3,250 -5.9%
43.49
US$141,342 		3,250 -5.9% 43.49 US$141,342
2026-05-15 2026-05-15 PrS Proposed sale
1.2
Coughlin Timothy

Director

Non-Executive Director
3,250
43.44
US$141,183 		3,250 43.44 US$141,183
2026-05-06 2026-05-06 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
22,500 -4.9%
43.95
US$988,875 		22,500 -4.9% 43.95 US$988,875
2026-05-06 2026-05-06 PlS Planned sale
2.4
ROTE WILLIAM E.

Chief Research Officer

Officer
2,763 -2.3%
43.95
US$121,434 		2,763 -2.3% 43.95 US$121,434
2026-05-06 2026-05-06 PlS Planned sale
2.7
Inrig Jula

CHIEF MEDICAL OFFICER

Officer
311 -0.3%
43.95
US$13,668 		311 -0.3% 43.95 US$13,668
2026-05-06 2026-05-06 PlS Planned sale
2.8
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
310 -0.3%
43.95
US$13,624 		310 -0.3% 43.95 US$13,624
2026-05-06 2026-05-06 PlS Planned sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
2,076 -1.9%
43.95
US$91,240 		2,076 -1.9% 43.95 US$91,240
2026-05-06 2026-05-06 PrS Proposed sale
2.8
CHRISTOPHER CLINE

Officer

Officer
310
43.95
US$13,624 		310 43.95 US$13,624
2026-05-06 2026-05-06 PrS Proposed sale
2.7
JULA INRIG

Officer

Officer
311
43.95
US$13,668 		311 43.95 US$13,668
2026-05-06 2026-05-06 PrS Proposed sale
2.4
ELIZABETH REED

Officer

Officer
2,076
43.95
US$91,240 		2,076 43.95 US$91,240
2026-05-06 2026-05-06 PrS Proposed sale
2.7
Dube Eric M

Officer

Officer
22,500
43.95
US$988,875 		22,500 43.95 US$988,875
2026-05-06 2026-05-06 PrS Proposed sale
2.4
ROTE WILLIAM E.

Officer

Officer
2,763
43.95
US$121,434 		2,763 43.95 US$121,434
2026-05-06 2026-05-05 PlS Planned sale
0.5
Baynes Roy D.
Non-Executive Director
4,500 -10.7%
46.65
US$209,925 		4,500 -10.7% 46.65 US$209,925
2026-05-06 2026-05-05 S Sale
2.7
Inrig Jula

CHIEF MEDICAL OFFICER

Officer
2,174 -1.9%
46.65
US$101,417 		2,174 -1.9% 46.65 US$101,417
2026-05-06 2026-05-05 S Sale
2.9
Heerma Peter

CHIEF COMMERCIAL OFFICER

Officer
2,174 -1.5%
46.65
US$101,417 		2,174 -1.5% 46.65 US$101,417
2026-05-06 2026-05-05 S Sale
2.8
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
2,181 -1.8%
46.65
US$101,744 		2,181 -1.8% 46.65 US$101,744
2026-05-06 2026-05-05 S Sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
2,174 -2.0%
46.65
US$101,417 		2,174 -2.0% 46.65 US$101,417
2026-05-05 2026-05-05 PrS Proposed sale
2.8
Christopher Cline

Officer

Officer
2,181
46.65
US$101,744 		2,181 46.65 US$101,744
2026-05-05 2026-05-05 PrS Proposed sale
2.4
Elizabeth E. Reed

Officer

Officer
2,174
46.65
US$101,417 		2,174 46.65 US$101,417
2026-05-05 2026-05-05 PrS Proposed sale
2.9
Peter Heerma

Officer

Officer
2,174
46.65
US$101,417 		2,174 46.65 US$101,417
2026-05-05 2026-05-05 PrS Proposed sale
2.7
Jula Inrig

Officer

Officer
2,174
46.65
US$101,417 		2,174 46.65 US$101,417
2026-05-05 2026-05-05 PrS Proposed sale
0.5
ROY BAYNES

Director

Non-Executive Director
4,500
46.65
US$209,925 		4,500 46.65 US$209,925
2026-05-06 2026-05-04 PlS Planned sale
2.7
Inrig Jula

CHIEF MEDICAL OFFICER

Officer
20,000 -15.2%
45.00
US$900,000 		20,000 -15.2% 45.00 US$900,000
2026-05-06 2026-05-04 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
8,000 -8.4%
45.00
US$360,000 		8,000 -8.4% 45.00 US$360,000
2026-05-06 2026-05-04 PlS Planned sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
20,000 -16.0%
45.00
US$900,000 		20,000 -16.0% 45.00 US$900,000
2026-05-04 2026-05-04 PrS Proposed sale
2.4
ELIZABETH REED

Officer

Officer
20,000
45.00
US$900,000 		20,000 45.00 US$900,000
2026-05-04 2026-05-04 PrS Proposed sale
1.9
JEFFREY MECKLER

Director

Non-Executive Director
8,000
45.00
US$360,000 		8,000 45.00 US$360,000
2026-05-04 2026-05-04 PrS Proposed sale
2.7
JULA INRIG

Officer

Officer
20,000
45.00
US$900,000 		20,000 45.00 US$900,000
2026-05-04 2026-05-01 PlS Planned sale
0.5
Baynes Roy D.
Non-Executive Director
9,750 -20.6%
44.22
US$431,145 		9,750 -20.6% 44.22 US$431,145
2026-05-01 2026-05-01 PrS Proposed sale
0.5
ROY BAYNES

Director

Non-Executive Director
9,750
44.22
US$431,145 		9,750 44.22 US$431,145
2026-04-23 2026-04-22 PlS Planned sale
2.4
ROTE WILLIAM E.

Chief Research Officer

Officer
9,100 -7.4%
39.09
US$355,719 		9,100 -7.4% 39.09 US$355,719
2026-04-22 2026-04-22 PrS Proposed sale
2.4
ROTE WILLIAM E.

Officer

Officer
9,100
39.09
US$355,719 		9,100 39.09 US$355,719
2026-04-15 2026-04-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
20 -0.0%
42.66
US$853 		20 -0.0% 42.66 US$853
2026-04-15 2026-04-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
7,165 -1.6%
41.75
US$299,139 		7,165 -1.6% 41.75 US$299,139
2026-04-15 2026-04-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
56,815 -11.4%
41.01
US$2,329,983 		56,815 -11.4% 41.01 US$2,329,983
2026-04-15 2026-04-15 PlS Planned sale
2.8
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
1,014 -0.9%
42.61
US$43,207 		1,014 -0.9% 42.61 US$43,207
2026-04-15 2026-04-15 PlS Planned sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
1,559 -1.5%
42.53
US$66,304 		1,559 -1.5% 42.53 US$66,304
2026-04-15 2026-04-15 PlS Planned sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
5,226 -4.7%
41.62
US$217,506 		5,226 -4.7% 41.62 US$217,506
2026-04-15 2026-04-15 PlS Planned sale
2.7
Inrig Jula

CHIEF MEDICAL OFFICER

Officer
1,018 -0.9%
42.61
US$43,377 		1,018 -0.9% 42.61 US$43,377
2026-04-15 2026-04-15 PrS Proposed sale
2.4
ELIZABETH REED

Officer

Officer
6,785
41.83
US$283,823 		6,785 41.83 US$283,823
2026-04-15 2026-04-15 PrS Proposed sale
2.7
Dube Eric M

Officer

Officer
64,000
41.09
US$2,629,833 		64,000 41.09 US$2,629,833
2026-04-15 2026-04-15 PrS Proposed sale
2.8
CHRISTOPHER CLINE

Officer

Officer
1,014
42.61
US$43,207 		1,014 42.61 US$43,207
2026-04-15 2026-04-15 PrS Proposed sale
2.7
JULA INRIG

Officer

Officer
1,018
42.61
US$43,377 		1,018 42.61 US$43,377
2026-04-16 2026-04-14 PlS Planned sale
2.9
Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
21,977 -34.2%
41.07
US$902,595 		21,977 -34.2% 41.07 US$902,595
2026-04-16 2026-04-14 PlS Planned sale
0.5
Baynes Roy D.
Non-Executive Director
6,750 -15.3%
42.12
US$284,310 		6,750 -15.3% 42.12 US$284,310
2026-04-16 2026-04-14 PlS Planned sale
0.5
Baynes Roy D.
Non-Executive Director
26,000 -37.0%
41.07
US$1,067,820 		26,000 -37.0% 41.07 US$1,067,820
2026-04-16 2026-04-14 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
8,000 -12.2%
41.07
US$328,560 		8,000 -12.2% 41.07 US$328,560
2026-04-15 2026-04-14 S Sale
2.9
Heerma Peter

CHIEF COMMERCIAL OFFICER

Officer
7,215 -4.9%
41.93
US$302,516 		7,215 -4.9% 41.93 US$302,516
2026-04-15 2026-04-14 S Sale
2.8
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
7,239 -5.8%
41.93
US$303,523 		7,239 -5.8% 41.93 US$303,523
2026-04-15 2026-04-14 PlS Planned sale
2.8
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
9 -0.0%
41.07
US$370 		9 -0.0% 41.07 US$370
2026-04-15 2026-04-14 S Sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
7,215 -6.1%
41.93
US$302,516 		7,215 -6.1% 41.93 US$302,516
2026-04-15 2026-04-14 PlS Planned sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
37,500 -23.9%
41.07
US$1,540,125 		37,500 -23.9% 41.07 US$1,540,125
2026-04-15 2026-04-14 S Sale
2.7
Inrig Jula

CHIEF MEDICAL OFFICER

Officer
7,215 -6.0%
41.93
US$302,516 		7,215 -6.0% 41.93 US$302,516
2026-04-14 2026-04-14 PrS Proposed sale
2.4
Elizabeth E. Reed

Officer

Officer
7,215
41.93
US$302,516 		7,215 41.93 US$302,516
2026-04-14 2026-04-14 PrS Proposed sale
2.7
Jula Inrig

Officer

Officer
7,215
41.93
US$302,516 		7,215 41.93 US$302,516
2026-04-14 2026-04-14 PrS Proposed sale
2.9
Peter Heerma

Officer

Officer
7,215
41.93
US$302,516 		7,215 41.93 US$302,516
2026-04-14 2026-04-14 PrS Proposed sale
2.8
Christopher Cline

Officer

Officer
7,239
41.93
US$303,522 		7,239 41.93 US$303,522
2026-04-14 2026-04-14 PrS Proposed sale
2.2
GARY A LYONS

Officer

Officer
8,000
30.70
US$245,600 		8,000 30.70 US$245,600
2026-04-14 2026-04-14 PrS Proposed sale
2.8
CHRISTOPHER CLINE

Officer

Officer
9
41.07
US$370 		9 41.07 US$370
2026-04-14 2026-04-14 PrS Proposed sale
2.4
ELIZABETH REED

Officer

Officer
37,500
41.07
US$1,540,125 		37,500 41.07 US$1,540,125
2026-04-14 2026-04-14 PrS Proposed sale
0.5
ROY BAYNES

Director

Non-Executive Director
32,750
41.29
US$1,352,130 		32,750 41.29 US$1,352,130
2026-04-14 2026-04-14 PrS Proposed sale
2.9
SANDRA CALVIN

Officer

Officer
21,977
41.07
US$902,595 		21,977 41.07 US$902,595
2026-04-15 2026-04-13 S Sale
2.8
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
65 -0.1%
28.85
US$1,875 		65 -0.1% 28.85 US$1,875
2026-04-13 2026-04-13 PrS Proposed sale
2.8
Christopher Cline

Officer

Officer
65
28.85
US$1,875 		65 28.85 US$1,875
2026-04-07 2026-04-06 PlS Planned sale
0.5
Baynes Roy D.
Non-Executive Director
10,000 -21.1%
33.00
US$330,000 		10,000 -21.1% 33.00 US$330,000
2026-04-06 2026-04-06 PrS Proposed sale
0.5
ROY BAYNES

Director

Non-Executive Director
10,000
33.00
US$330,000 		10,000 33.00 US$330,000
2026-04-02 2026-04-01 PlS Planned sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
10,000 -8.7%
30.00
US$300,000 		10,000 -8.7% 30.00 US$300,000
2026-04-02 2026-04-01 PlS Planned sale
2.4
REED ELIZABETH E

Chief Legal Officer and GC

Officer
10,000 -8.7%
30.00
US$300,000 		10,000 -8.7% 30.00 US$300,000
2026-04-02 2026-04-01 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
25,098 -5.5%
31.46
US$789,583 		25,098 -5.5% 31.46 US$789,583
2026-04-02 2026-04-01 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
34,902 -7.1%
30.55
US$1,066,256 		34,902 -7.1% 30.55 US$1,066,256
2026-04-01 2026-04-01 PrS Proposed sale
2.7
Dube Eric M

Officer; Director

Executive Director
60,000
30.93
US$1,855,655 		60,000 30.93 US$1,855,655
Explore more

More insider trading research around Travere Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America